So not only are we using an overfitting model that probably can't handle truly novel proteins, we have stopped actually doing the research to notice when this happens. Pretty bad.
AlphaFold is able to predict novel folds, see https://www.nature.com/articles/s42003-022-03357-1
Second, how can they possibly know this fold isn't actually in the ENTIRE PDB? I doubt very much that the can. The PDB is enormous.
I was merely addressing your claim in the previous post.
> Second, how can they possibly know this fold isn't actually in the ENTIRE PDB? I doubt very much that the can. The PDB is enormous.
There are well-established fold classification databases (such as SCOP and CATH) where you can query newly solved structures using several structural comparison algorithms (DALI, TM-align, etc).
The Protein Data Bank might be enormous, but there is an enormous amount of structural redundancy as well, from which reduced datasets can be (and are) derived. Protein structure is, after all, much more conserved than sequence, mainly due to the physicochemical principles that govern folding and stability.
> Where are the AI-driven breakthroughs
> are we just using AI to remix existing general knowledge, while making no progress of any sort in any field using it?
The obvious example of a highly significant AI-driven breakthrough is Alphafold [1]. It has already had a large impact on biotech, helping with drug discovery, computational biology, protein engineering...
[1] https://blog.google/technology/ai/google-deepmind-isomorphic...